Trial Profile
A phase II trial investigating the efficacy of calcitonin for the treatment of osteoporosis and other bone degenerative diseases
Status:
Active, no longer recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Feb 2016
Price :
$35
*
At a glance
- Drugs Calcitonin (Primary) ; Calcitonin
- Indications Osteoporosis
- Focus Therapeutic Use
- Sponsors Bone Medical
- 06 Sep 2007 New trial record.
- 01 Aug 2007 Results published in a Bone Medical media release.
- 19 Jul 2007 Interim results published in a Bone Medical media release.